Shares of cancer-drug maker Celgene ( CELG) sank after research firm SG Cowen initiated coverage of the stock with a neutral rating.

While Cowen's biotech analyst Phil Nadeau says revenue from the company's Revlimid should reach $2.3 billion in 2010 from $331 million for all of 2006, the drug's success is already priced into the stock, which is "modestly overvalued," he believes. Nadeau says he would look for a pullback before building a position. Shares fell 3.4% to $44.39.

MicroIslet ( MII) fell despite an announcement that the company's transplantation studies on diabetic primates reached a six-month milestone. After jumping early in the day, shares were lower by 9 cents, or 5%, to $1.70.

Shares of medical-aesthetics company Syneron ( ELOS) were jumping 15.6% to $21.39 after the company reported earnings and reiterated its guidance. Syneron's quarterly revenue reached $27.5 million, up 37% from a year ago and was a record high. Overall, the company earned $8.9 million, or 32 cents a share, including stock-based compensation expenses.

Excluding charges, the company earned $11.3 million, or 41 cents a share, in the quarter, up 22% from last year. Analysts were expecting the company to earn 39 cents a share. The company said it was on track to meet its previously announced guidance, which in February called for revenue of between $113 million and $120 million for the full year.

Among other health care stocks on the move were pharmaceutical company NitroMed ( NTMD), which was gaining 14.1% to $2.91, drug developer Taro Pharmaceutical Industries ( TARO), up 7.7% to $12.81, biotech ICAgen ( ICGN), higher by 7.1% to $1.20, and Spectrum Pharmaceuticals ( SPPI), up 3.4% to $3.68.

Accentia Biopharmaceuticals ( ABPI) was down 1.6% to $3.03, Ivax Diagnostics ( IVD) fell 8.2% to $1.56, Oscient Pharmaceuticals ( OSCI) was down 6% to $1.25, Nyer Medical Group ( NYER) lost 9.7% to $2.80, Alpharma ( ALO) was down 6.6% to $21.65, and Rigel Pharmaceuticals ( RIGL) was losing 3.8% to $9.20.

If you liked this article you might like

Nationwide Egg Recall Expanded

Nationwide Egg Recall Expanded

10 Toy Fads That Have Faded

10 Toy Fads That Have Faded

Boomers Feel Recession Burden, Blame

Boomers Feel Recession Burden, Blame

KFC Franchisees Want 'Fried' to Be the Focus

KFC Franchisees Want 'Fried' to Be the Focus

Heavy Weights: More Expensive, Less Effective

Heavy Weights: More Expensive, Less Effective